Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001893521-21-000001
Filing Date
2021-11-16
Accepted
2021-11-15 19:37:15
Documents
1
Effectiveness Date
2021-11-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4937
  Complete submission text file 0001893521-21-000001.txt   6025
Mailing Address C/O GAINGELS MANAGEMENT LLC 3 MAIN STREET, SUITE 214 BURLINGTON VT 05401
Business Address 3 MAIN STREET SUITE 214 BURLINGTON VT 05401 9178433621
Gaingels Delix Therapeutics LLC (Filer) CIK: 0001893521 (see all company filings)

EIN.: 873240265 | State of Incorp.: VT | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-421250 | Film No.: 211413576